CCWM
RMD icon

Cassaday & Co Wealth Management’s ResMed RMD Stock Holding History

Cassaday & Co Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$225 Buy
+1
New +$249 ﹤0.01% 1256

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cassaday & Co Wealth Management's RMD Position: Q1 2026 in Review

Cassaday & Co Wealth Management opened a new position in ResMed (RMD) in Q1 2026: 1 share worth $225. The stake represents ﹤0.01% of the portfolio and ranks #1256 among its holdings.

938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Cassaday & Co Wealth Management held 1 share of ResMed worth $225 as of Q1 2026.
  • ResMed was a new Cassaday & Co Wealth Management position in Q1 2026.
  • ResMed made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q1 2026, its #1256 holding.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.